Better Experiences in Substance Treatment: A Brief Alcohol-focused Intervention Tailored for Patients in Opioid Agonist Treatment
Key facts
- Who runs it
- University of Notre Dame
- Where
- Notre Dame, United StatesSee the site
- Trial code
- Status
- Recruiting
- People taking part
- 60 people, planned
- Started
- 24 Mar 2026
- Expected to end
- 1 Mar 2027
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- Brief opioid-informed alcohol treatment
- Record updated
- 9 June 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 7 criteriaShow less
Who can take part
- Participants must be taking prescribed buprenorphine for at least 2 weeks
- Participants must be 18 years or older
- Meet DSM-5 criteria for alcohol use disorder (AUD)
- Participants must report alcohol use ≥ 1 day/week on average in the past 28 days
- Participants must be able to read simple English
Who cannot take part
- Currently receiving formal alcohol use treatment
- Currently experiencing psychosis
Where in United States
- The University of Notre DameNotre Dame, United StatesContact: Beth A Arnold, M.S.Taking people
About the trial
What the trial wants to find out
This study will help determine the feasibility and acceptability of a brief opioid-informed alcohol intervention in patients receiving prescribed buprenorphine for opioid use who are currently drinking alcohol. It will also provide initial information on whether the intervention improves outcomes related to alcohol use. The results of this proof-of-concept study will inform whether a future larger clinical trial is warranted.
The 2 groups in the trial
- Treatment As UsualNo study treatment, for comparison
No intervention is administered. All participants in this study receive prescribed buprenorphine for opioid use disorder and may, related to this, receive behavioral intervention focused on medication adherence and preventing opioid relapse. Treatment As Usual refers to receiving this and no additional intervention.
- Experimental: Brief opioid-informed alcohol treatmentTreatment being tested
The brief opioid-informed alcohol treatment is based upon principles of Motivation Enhancement Therapy (MET) and Cognitive Behavioral Therapy (CBT) tailored to the needs of patients in opioid treatment. Delivered once per week for 4 weeks.
Treatment: Brief opioid-informed alcohol treatment
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Better Experiences in Substance Treatment: A Brief Alcohol-Focused Intervention Tailored for Patients in Opioid Agonist Treatment
- Record updated
- 9 June 2026